| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Radiation Therapy Department, Johannesburg General Hospital
This excerpt was created in the absence of an abstract.
It has been shown that when relatively short-lived radioactive sources are used in therapy, there is a critical interval of time during which the biological efficacy is approaching a maximum. Clinical dosage prescriptions must be calculated for this critical interval. Doses based on longer or shorter time intervals are likely to prove excessive. A formula is given whereby the critical biological interval can be determined for isotopes having various half-lives; and a nomogram relates tissue tolerance and cancer lethal doses to the half-life of the
-ray source used. It is suggested that permanent implants of moderately long-lived sources may have certain clinical advantages.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |